{
    "1694726472962068799": {
        "attachments": {
            "media_keys": [
                "13_1694726258289188864"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-08-24T15:00:52.000Z",
        "edit_history_tweet_ids": [
            "1694726472962068799"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 40,
                    "normalized_text": "CVRM",
                    "probability": 0.6252,
                    "start": 37,
                    "type": "Other"
                },
                {
                    "end": 165,
                    "normalized_text": "CVRM disease",
                    "probability": 0.7435,
                    "start": 154,
                    "type": "Other"
                }
            ],
            "urls": [
                {
                    "description": "Explore our resources and solutions to transform the lives of people with cardiovascular disease, heart failure, chronic kidney disease and diabetes.",
                    "display_url": "learn.az/6013PoqYF",
                    "end": 260,
                    "expanded_url": "https://learn.az/6013PoqYF",
                    "images": [
                        {
                            "height": 500,
                            "url": "https://pbs.twimg.com/news_img/1788554627496943616/kcYIswNj?format=jpg&name=orig",
                            "width": 900
                        },
                        {
                            "height": 150,
                            "url": "https://pbs.twimg.com/news_img/1788554627496943616/kcYIswNj?format=jpg&name=150x150",
                            "width": 150
                        }
                    ],
                    "start": 237,
                    "status": 200,
                    "title": "Cardiovascular, Renal and Metabolism (CVRM) | AstraZeneca",
                    "unwound_url": "https://www.astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism.html?utm_source=twitter&utm_medium=cvrm+narrative+roll+out+2023&utm_term=12004&utm_content=cvrm",
                    "url": "https://t.co/Q9xV3Ix416"
                },
                {
                    "display_url": "pic.twitter.com/VU7EQI09bJ",
                    "end": 284,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1694726472962068799/video/1",
                    "media_key": "13_1694726258289188864",
                    "start": 261,
                    "url": "https://t.co/VU7EQI09bJ"
                }
            ]
        },
        "id": "1694726472962068799",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 1,
            "impression_count": 9127,
            "like_count": 18,
            "quote_count": 0,
            "reply_count": 1,
            "retweet_count": 6
        },
        "text": "Cardiovascular, renal and metabolic (CVRM) conditions affect hundreds of millions of people around the world. We estimate that one in three people with a CVRM disease are living with two or more of these chronic diseases. Find out more: https://t.co/Q9xV3Ix416 https://t.co/VU7EQI09bJ"
    }
}